New research is under way studying the most effective range of vitamin D in reducing symptoms of MS.
Your search results: multiple sclerosis
A study discovered that daily sun exposure during adolescence and a lower BMI may delay the development of multiple sclerosis.
Dr Cannell reviews research covering disease rates and vitamin D levels among African Americans and discusses information which should be known to all.
Research published yesterday suggest that birth month has a significant association with multiple sclerosis (MS), with as much as a 12% difference in risk.
According to an observational study, increased vitamin D is associated with less disability and increased preservation of grey matter in patients with multiple sclerosis.
A recent study discovered that vitamin D status is positively associated with gray matter volume in patients with multiple sclerosis (MS).
Researchers at UCSF set out to determine if there is a link between vitamin D status and developing new lesions in patients with relapsing multiple sclerosis.
Researchers reveal molecular and genetic evidence that vitamin D benefits patients with multiple sclerosis.
Dr Cannell discusses the epidemiology of schizophrenia as well as recent research examining the link between vitamin D and schizophrenia.
A new study suggests that low vitamin D status during infancy is associated with an increased risk for developing multiple sclerosis.
The average vitamin D scientist is now taking 5,000 IU/day. Dr Cannell discusses this study as well other other interesting vitamin D facts.
There were 3,600 papers published about vitamin D in 2012. Dr Grant summarizes the top 16 vitamin D papers of this past year.
In a recent review, Doctor Jordan Kempker of Emory University School of Medicine in Atlanta, summarized what we know about sepsis and vitamin D.
A recent animal study has given a new perspective on the role of vitamin D and sunlight in the development of multiple sclerosis.
Recent research from Australia suggests that vitamin D levels are not associated with future depression.
Dr. Bill Grant discusses his study which evaluated economic benefit of increasing vitamin D levels to 40 ng/ml in Canadians.
A pilot study suggests that calcipotriol may be an alternative treatment for alopecia areata, a type of hair loss.
In the first trial of its kind, researchers have found that vitamin D supplementation reduces severity of restless legs syndrome.
Recently, researchers examined several environmental factors implicated in multiple sclerosis. Brant Cebulla discusses the potential factors contributing to the incidence of the disease.
Dr. Cannell discusses the case of a 58-year-old woman who developed high blood calcium on a physiological dose of vitamin D, combined with an excessive dose of calcium.